Login to Your Account

Clinic Roundup

Wednesday, February 13, 2013
• Lorus Therapeutics Inc., of Toronto, said that biomarker data for its lead cancer therapy, LOR-253, will be presented in April at the 2013 annual meeting of the American Association for Cancer Research in Washington.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription